Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,964 public trials 1,826 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Active, Not Recruiting

Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas

NCT02223208

Conditions
ALK- Anaplastic Large Cell Lymphoma (ALCL), Angioimmunoblastic T-cell Lymphoma (AITL), Hemic and Lymphatic Diseases, +15 more
Locations
  • Ospedale SS. Antonio e Biagio e Cesare Arrigo Alessandria, AL, Italy
  • Policlinico S. Orsola Malpighi Bologna, BO, Italy
  • Spedali Civili Brescia, BS, Italy
  • Ospedale Businco Cagliari, CA, Italy
View all 27 locations
View Trial Details
Active, Not Recruiting

PTLD: Multicentric Retrospective Study

NCT06422715

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +3 more
Locations
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Ematologia Milan, MI, Italy
  • Centro Di Riferimento Oncologico Di Aviano, S.O.C. Oncologia Medica e dei Tumori Immunocorrelati Aviano, Italy
  • Azienda Ospedaliera Papa Giovanni XXIII - Ematologia Bergamo, Italy
  • A.O. UNIVERSITARIA POLICLINICO S.ORSOLA-MALPIGHI DI BOLOGNA - Istituto di Ematologia "Seragnoli" Bologna, Italy
View all 21 locations
View Trial Details
Active, Not Recruiting

Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)

NCT02570542

Conditions
Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up Only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent and Follow up Only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent and Follow Up Only) Montvale, New Jersey, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Evaluation of the Safety and Efficacy of the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia With p53 Dysfunction

NCT03734198

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • Chu Amiens Sud Amiens, France
  • CH Annecy Genevois - Hématologie A3 Annecy, France
  • CHU Jean Minjoz - Hématologie Besançon, France
  • Hôpital Avicenne - Centre de Recherche Clinique Bobigny, France
View all 24 locations
View Trial Details

Related conditions